GLUCAGON ANTAGONISTS/INVERSE AGONISTS,申请号WO2000DK00264-传众专利搜索

发明名称	GLUCAGON ANTAGONISTS/INVERSE AGONISTS
摘要	A novel class of compounds, which act to antagonize the action of the glucagon hormone on the glucagon receptor. Owing to their antagonizing effect of the glucagon receptor the compounds may be suitable for the treatment and/or prevention of any glucagon-mediated conditions and diseases such as hyperglycemia, Type 1 diabetes, Type 2 diabetes and obesity.
申请公布号	WO0069810(A1)	申请公布日期	2000.11.23
申请号	WO2000DK00264	申请日期	2000.05.16
申请人	NOVO NORDISK A/S;AGOURON PHARMACEUTICALS, INC.	发明人	LING, ANTHONY;PLEWE, MICHAEL, BRUNO;TRUESDALE, LARRY, KENNETH;LAU, JESPER;MADSEN, PETER;SAMS, CHRISTIAN;BEHRENS, CARSTEN;VAGNER, JOSEF;CHRISTENSEN, INGE, THOEGER;LUNDT, BEHREND, FREDERIK;SIDELMANN, ULLA, GROVE;THOEGERSEN, HENNING
分类号	A61K31/197;A61K31/341;A61K31/343;A61K31/351;A61K31/36;A61K31/381;A61K31/4035;A61K31/404;A61K31/41;A61K31/4184;A61K31/423;A61K31/4245;A61K31/428;A61K31/429;A61K31/437;A61K31/44;A61K31/445;A61K31/4468;A61K31/47;A61K31/519;A61K45/00;A61P3/04;A61P3/08;A61P3/10;A61P43/00;C07C237/36;C07C237/42;C07C243/38;C07C271/56;C07C271/58;C07C275/24;C07C275/26;C07C275/28;C07C275/30;C07C275/32;C07C275/34;C07C275/36;C07C275/38;C07C275/40;C07C275/42;C07C275/60;C07C275/62;C07C311/39;C07C311/47;C07C317/22;C07C317/32;C07C317/42;C07C323/21;C07C323/37;C07C323/44;C07C323/62;C07D209/08;C07D209/48;C07D211/58;C07D211/60;C07D213/75;C07D215/38;C07D231/38;C07D231/40;C07D235/30;C07D257/04;C07D257/06;C07D277/72;C07D277/82;C07D295/13;C07D295/135;C07D307/68;C07D307/85;C07D317/66;C07D319/18;C07D319/20;C07D333/20;C07D333/38;C07D333/40;C07D333/60;C07D333/68;C07D333/70;C07D339/06;C07D403/12;C07D405/12;C07D409/12;C07D413/12;C07D417/12;C07D487/04;C07D513/04;(IPC1-7):C07C237/32;C07C243/24;C07C271/40;C07D333/04;A61K31/15;A61K31/165;A61K31/17;A61K31/33	主分类号	A61K31/197
代理机构		代理人
主权项
地址